These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 27487786)

  • 1. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Response of IBS-SSS, AR, and IBS-QOL in IBS Clinical Effect Evaluation].
    Bian LQ; Lu F; Li ZH; Ll BS; Gao R; Wang FY; Zhang YQ; Tang XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Oct; 36(10):1191-1196. PubMed ID: 30641005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
    Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
    Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treating irritable bowel syndrome with diarrhea patients by yigan fupi decoction: a randomized controlled trial].
    Chen MX; Chen JX; Xia L; Fu R; Lu Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):656-60. PubMed ID: 25046944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of jianpi tiaogan wenshen recipe in treating diarrhea-predominant irritable bowel syndrome].
    Gao WY; Wang CH; Lin YF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan; 30(1):13-7. PubMed ID: 20353024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
    Wang XX; Luo RJ; She B; Chen Y; Guo J
    Trials; 2014 Jul; 15():273. PubMed ID: 25002196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Changjishu soft elastic capsule in treatment of diarrhea-predominant irritable bowel patients with liver-qi stagnation and spleen deficiency syndrome: a randomized double-blinded controlled trial].
    Gao WY; Lin YF; Chen SQ; Lu YP; Yang Z; Gong Y; Liu Y; Wang LX; Wang CH
    Zhong Xi Yi Jie He Xue Bao; 2009 Mar; 7(3):212-7. PubMed ID: 19284948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.
    Tan X; Zhao XJ; Li JX; Xie CE; Pei WJ; Shi L; Kou FS; Yuan YL; Xue XX
    Medicine (Baltimore); 2020 Dec; 99(52):e23868. PubMed ID: 33350782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Lai HC; Wang KT; Liao WL; Hsieh CL
    J Ethnopharmacol; 2019 Jun; 238():111889. PubMed ID: 31009707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-irritable Bowel Syndrome Syrup Improves Constipation-Predominant Irritable Bowel Syndrome: A Randomized, Placebo-Controlled Trial.
    Pazhouh HK; Hosseini SMA; Taghipour A; Hamedi S; Noras M
    Chin J Integr Med; 2020 Oct; 26(10):729-735. PubMed ID: 32623701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL; Carson RT; Andrae DA
    Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of herb-separated moxibustion at Jinsuo (GV 8)-eight-diagram points on diarrhea-type irritable bowel syndrome of liver stagnation and spleen deficiency].
    Hao LJ; Shi ZM
    Zhongguo Zhen Jiu; 2020 Jul; 40(7):702-6. PubMed ID: 32648391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
    Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.